| Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers J Adamski, B Godman, G Ofierska-Sujkowska, B Osińska, H Herholz, ... BMC health services research 10, 1-16, 2010 | 330 | 2010 |
| The ‘wise list’–a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm LL Gustafsson, B Wettermark, B Godman, E Andersén‐Karlsson, ... Basic & clinical pharmacology & toxicology 108 (4), 224-233, 2011 | 294 | 2011 |
| Efficacy of mobile apps to support the care of patients with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials BC Bonoto, VE de Araújo, IP Godói, LLP de Lemos, B Godman, M Bennie, ... JMIR mHealth and uHealth 5 (3), e6309, 2017 | 287 | 2017 |
| Policies for biosimilar uptake in Europe: an overview E Moorkens, AG Vulto, I Huys, P Dylst, B Godman, S Keuerleber, B Claus, ... PloS one 12 (12), e0190147, 2017 | 235 | 2017 |
| Physicians’ knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature RS Md Rezal, MA Hassali, AA Alrasheedy, F Saleem, FA Md Yusof, ... Expert review of anti-infective therapy 13 (5), 665-680, 2015 | 230 | 2015 |
| Economics of myocardial perfusion imaging in Europe—the EMPIRE Study SR Underwood, B Godman, S Salyani, JR Ogle, PJ Ell European heart journal 20 (2), 157-166, 1999 | 227 | 1999 |
| Response to the novel corona virus (COVID-19) pandemic across Africa: successes, challenges, and implications for the future OO Ogunleye, D Basu, D Mueller, J Sneddon, RA Seaton, ... Frontiers in pharmacology 11, 1205, 2020 | 208 | 2020 |
| Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications B Godman, W Shrank, M Andersen, C Berg, I Bishop, T Burkhardt, ... Expert review of pharmacoeconomics & outcomes research 10 (6), 707-722, 2010 | 205 | 2010 |
| Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance B Godman, B Wettermark, M Hoffmann, K Andersson, A Haycox, ... Expert review of pharmacoeconomics & outcomes research 9 (1), 65-83, 2009 | 184 | 2009 |
| Ongoing initiatives to improve the quality and efficiency of medicine use within the public healthcare system in South Africa; a preliminary study JC Meyer, N Schellack, J Stokes, R Lancaster, H Zeeman, D Defty, ... Frontiers in pharmacology 8, 751, 2017 | 178 | 2017 |
| Are new models needed to optimize the utilization of new medicines to sustain healthcare systems? B Godman, RE Malmström, E Diogene, A Gray, S Jayathissa, A Timoney, ... Expert review of clinical pharmacology 8 (1), 77-94, 2015 | 164 | 2015 |
| The implementation of managed entry agreements in Central and Eastern Europe: findings and implications A Ferrario, D Arāja, T Bochenek, T Čatić, D Dankó, M Dimitrova, J Fürst, ... Pharmacoeconomics 35, 1271-1285, 2017 | 162 | 2017 |
| Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications B Godman, B Wettermark, M Van Woerkom, J Fraeyman, ... Frontiers in pharmacology 5, 106, 2014 | 161 | 2014 |
| Strategies to improve antimicrobial utilization with a special focus on developing countries B Godman, A Egwuenu, M Haque, OO Malande, N Schellack, S Kumar, ... Life 11 (6), 528, 2021 | 159 | 2021 |
| Non-prescription sale and dispensing of antibiotics in community pharmacies in Zambia AC Kalungia, J Burger, B Godman, JO Costa, C Simuwelu Expert review of anti-infective therapy 14 (12), 1215-1223, 2016 | 156 | 2016 |
| Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries … B Godman, M Haque, J McKimm, M Abu Bakar, J Sneddon, J Wale, ... Current medical research and opinion 36 (2), 301-327, 2020 | 155 | 2020 |
| Barriers for access to new medicines: searching for the balance between rising costs and limited budgets B Godman, A Bucsics, P Vella Bonanno, W Oortwijn, CC Rothe, A Ferrario, ... Frontiers in Public Health 6, 328, 2018 | 153 | 2018 |
| Policies to enhance prescribing efficiency in Europe: findings and future implications B Godman, W Shrank, M Andersen, C Berg, I Bishop, T Burkhardt, ... Frontiers in pharmacology 1, 141, 2011 | 151 | 2011 |
| Ongoing pharmaceutical reforms in France: implications for key stakeholder groups C Sermet, V Andrieu, B Godman, E Van Ganse, A Haycox, JP Reynier Applied health economics and health policy 8, 7-24, 2010 | 150 | 2010 |
| Drug utilization research: methods and applications M Elseviers, B Wettermark, AB Almarsdóttir, M Andersen, R Benkö, ... John Wiley & Sons, 2016 | 144 | 2016 |
Johanna C MeyerProfessor, School of Pharmacy; Head: SAVIC; Sefako Makgatho Health Sciences UniversityDirección de correo verificada de smu.ac.za
